Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Multidrug evolutionary strategies to reverse antibiotic resistance
2015 Science
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
2012
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Artificial intelligence in healthcare: past, present and future
2017 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study
2014
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Telavancin: A Novel Lipoglycopeptide
2009
Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
2019
The Impact of ICD-9-CM Code Rank Order on the Estimated Prevalence of Clostridium difficile Infections
2011
Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration
2010
Natural products: A continuing source of novel drug leads
2013 Standout
Urinary Tract Infection in Male Veterans
2012
Natural products: An evolving role in future drug discovery
2011 Standout
Clostridium difficileInfections among Hospitalized Children, United States, 1997–2006
2010
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
2015
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008
2012
Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital
2012
Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates
2011
Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings: SHEA/HICPAC Position Paper
2008
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Variability in drug metabolizing enzyme activity in HIV-infected patients
2010
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
2003 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
2020
Hospital-Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients
2015
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Benchmarking antimicrobial drug use in hospitals
2012
Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis
2012
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study
2012
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
2015
Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias
2014
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
2011
Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features
2019
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Drug Interactions Between Antiretroviral Drugs and Comedicated Agents
2003
Mining peripheral arterial disease cases from narrative clinical notes using natural language processing
2017
Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort
2018
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Urinary Tract Infection Syndromes
2013 Standout
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
2011
Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
2005 Standout
The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC
2009
An overview of the antimicrobial resistance mechanisms of bacteria
2018
The pros, cons, and many unknowns of probiotics
2019 Standout
Hepatocellular carcinoma
2022 Standout
Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
2017
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
2014
Interventions to improve hand hygiene compliance in patient care
2017 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.
2003 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care
2016
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Fecal Microbiota Transplant
2015
Hospital Ward Antibiotic Prescribing and the Risks ofClostridium difficileInfection
2015
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
2012
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Development potential of rifalazil and other benzoxazinorifamycins
2006
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Novel Carbapenem Antibiotics for Parenteral and Oral Applications: In Vitro and In Vivo Activities of 2-Aryl Carbapenems and Their Pharmacokinetics in Laboratory Animals
2012
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Variability in Antibiotic Use Across Nursing Homes and the Risk of Antibiotic-Related Adverse Outcomes for Individual Residents
2015
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Computerized advice on drug dosage to improve prescribing practice
2008
Natural product and natural product derived drugs in clinical trials
2014 Standout
Multistate Point-Prevalence Survey of Health Care–Associated Infections
2014 Standout
In Vitro Activities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
2012
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Antibiotic prophylaxis in cirrhosis: Good and bad
2015
Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use
2014
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Works of Amy Pakyz being referenced
Variability in Activity of Hepatic CYP3A4 in Patients Infected with HIV
2000
Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres
2013
Trends in Antibacterial Use in US Academic Health Centers
2008
Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols
2009
Diversity of Antimicrobial Use and Resistance in 42 Hospitals in the United States
2008
The Utility of Hospital Antibiograms as Tools for Guiding Empiric Therapy and Tracking Resistance: Insights from the Society of Infectious Diseases Pharmacists
2007
Use of International Classification of Diseases, Ninth Revision Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
2009
Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers
2009
Economic Impact of Clostridium difficile Infection in a Multihospital Cohort of Academic Health Centers
2011
Performance of the Present-on-Admission Indicator for Clostridium difficile Infection
2015
Rifaximin: A New Treatment for Travelers' Diarrhea
2004
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
2009
Statin use and the risk of Clostridium difficile in academic medical centres
2012
Statin use and infections in Veterans with cirrhosis
2013
Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship
2012
Antifungal use in hospitalized adults in U.S. academic health centers
2011
Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system
2009